Literature DB >> 6800751

Nitroglycerin intravenous infusion.

G T Elliott, S L Quinn.   

Abstract

The treatment of various cardiovascular problems with intravenous nitroglycerin is widely practiced though unapproved. The uses of iv nitroglycerin include improvement of the hemodynamics of left ventricular failure and cardiogenic shock associated with infarction, control of hypertension during coronary artery surgery, and possibly, reduction of acute myocardial infarct size. The popularity of this treatment in the absence of an FDA-approved commercial product has forced some hospitals to prepare the drug extemporaneously, and the advantages and disadvantages of preparation and storage techniques are presented.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6800751     DOI: 10.1177/106002808201600304

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  3 in total

Review 1.  Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.

Authors:  M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 2.  Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.

Authors:  E M Sorkin; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of organic nitrates.

Authors:  M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.